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Background. Direct percutaneous endoscopic jejunostomy (DPEJ) insertion is a useful technique for artiﬁcial nutritional support
in selected patients. However, it is technically diﬃcult and most case series report signiﬁcant procedural failure rates. Methods.W e
reviewed our case series of DPEJ insertions, done in a tertiary care referral centre from 2002 to 2008. Patients were selected for
DPEJiftheyrequiredartiﬁcial entericnutritionalsupportbutwereunsuitableforendoscopicgastrostomy.Ourtechniqueincludes
selective usage of a long drainage access needle for gut luminal puncture, selective ﬂuoroscopic guidance and selective usage of
general anaesthesia. Results. Of 40 consecutive patients undergoing attempted DPEJ insertion, 39/40 (97.5%) had a successful
procedure. Sixteen cases (40%) required the drainage access needle for completion, nineteen cases (47.5%) were done with
ﬂuoroscopy, and ﬁve cases (12.5%) were done under general anaesthesia. There were no procedural complications. Conclusions.
This technique led to a high completion rate and low complication rate. With appropriate care and expertise, DPEJ insertion is
reliable and safe.
Copyright © 2009 G. W. Moran and N. C. Fisher. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Artiﬁcial enteric nutritional support is vital in the manage-
ment of subjects who are unable to maintain oral nutrition
duringorfollowingconditionssuchasuppergastrointestinal
malignancy surgical resection, cerebrovascular disease, or
dysmotility [1]. In some of these situations, postpyloric
feeding is required [2]. For delivery of postpyloric feeding,
the direct percutaneous endoscopic jejunostomy (DPEJ) is
the device of choice for many clinicians because it a secure,
highcalibredevice(typically15Frormore)whichisunlikely
to block and cannot migrate, in contrast to other devices that
are easier to place such as nasojejunal or PEG-J tubes [3–6].
However its limitations are that it is generally more diﬃcult
to place and with a higher risk of complications, so its usage
is not widespread.
In the past six years at our institution we have adopted
the DPEJ as the device of choice for artiﬁcial nutrition in a
smallgroupofhighlyselectedpatients,principallythosewith
complications of advanced upper GI malignancy. During
this time our technique has been reﬁned to include selective
usage of a long drainage access needle for enteric access, in
ordertomaximisetechnicalsuccessrateandminimiseriskof
complications.Wedescribehereourtechniqueandoutcome.
Data for this review were obtained by case note review of all
patients on a prospectively held database of attempted DPEJ
insertions.
2. Patients andMethods
2.1. Patient Selection. Patients were considered for DPEJ as
the primary means of artiﬁcial nutritional support if they
were unable to maintain nutrition orally and if conven-
tional endoscopic gastrostomy insertion was inappropriate
(because of gastric malignancy, resection or dysmotility). All
patients had a history of weight loss of >5% previous body
weight. For patients with malignancy, obstructing lesions
were managed with enteric stents, and DPEJs were reserved
for cases not suitable for stenting. DPEJ insertion was
avoided if active respiratory infection or failure was present,2 Diagnostic and Therapeutic Endoscopy
Figure 1: Fluoroscopic image localising endoscope position in the
proximal jejunum (this patient has undergone gastrectomy).
and in patients in the terminal phase of malignant disease,
unlesstherewasanexplicitintentionofusingaDPEJtoallow
a patient to be discharged home for terminal palliative care.
2.2. Technique—General Considerations. Conscious sedation
is used where possible, with intravenous midazolam with or
without pethidine. General anaesthesia is used in selected
caseseitherforpatientanxietyorafterafailedearlierattempt
under conscious sediation. Antibiotic prophylaxis with 2.2g
coamoxiclav is used. Intravenous hyoscine is used during the
procedure, immediately prior to trochar insertion.
2.3. DPEJ Insertion. The technique is a modiﬁcation of the
original DPEJ procedure as described by Shike et al. [7]. The
choice of endoscope used depends upon whether previous
upper GI surgery has been done; if the upper GI tract is
intact, an enteroscope (with overtube) is usually needed;
shorter endoscopes may be used if part of the upper GI tract
has been resected or anastomosed [8]. Our practice is to
always have ﬂuoroscopy available during the procedure.
Theendoscopeisadvancedintotheﬁrstloopofjejunum;
with experience, this loop is usually readily identiﬁable.
The endoscope position can usually be conﬁrmed by ﬁnger
indentation in the left upper quadrant or with ﬂuoroscopy
(if a gastrojejunostomy has been done then the endoscope
position is more variable). Transillumination may also be
seen here but we do not consider this a prerequisite to
trochar insertion. The abdominal wall is then cleansed. Local
anaesthetic is inserted at the indentation site, and a 21G
pilot needle (4cm long) is advanced and is used to search
for the jejunal lumen. At this point intermittent ﬂuoroscopy
can be used to help guide the needle into the gut lumen
immediately in front of the endoscope tip (Figures 1 and 2).
We also use continuous aspiration on the pilot needle; when
air is aspirated the needle should be endoscopically visible
at the same time to conﬁrm entry into the correct bowel
loop and to help exclude puncture of interposed loops of
bowel. If the needle is not visible after aspirating air then it
may be in a superimposed loop of gut, and the endoscope
may need to be moved into a diﬀerent loop to achieve
as a f ep u n c t u r es i t e .I no u rp r a c t i c ew ed on o tg e n e r a l l y
have rotational ﬂuoroscopy available so judgment on a safe
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Figure 2: A 21G needle is advanced into the gut lumen with
intermittent ﬂuoroscopic guidance (panels (a) and (b)).
puncturesiterequiresinterpretation ofaircontrastinthegut
on ﬂuoroscopy, use of air aspiration on the pilot needle and
transillumination or ﬁnger indentation. After an appropriate
puncture site has been identiﬁed, a trochar or drainage
access needle is advanced alongside or in place of the 21G
needle.Ifthereisuncertaintyregardingthedistancefromthe
abdominal wall to the gut lumen, for example, when the gut
lumencannotbeenteredwitha21Gneedle,thenﬂuoroscopy
may be helpful to ensure that there are no loops of bowel
between the jejunal loop and the abdominal wall and to
help guide the direction of the needle. In this situation,
several needle passes with intermittent ﬂuoroscopy may be
required for successful puncture. Once the gut has been
successfuly punctured, the trochar or needle is then snared,
and the procedure can be completed as for a conventional
PEG insertion (Figures 3 and 4). Our unit normally uses a
Fresenius 15Fr PEG kit for these procedures.
The principal variation on previous techniques that
we use is the drainage access needle as an alternative to
the conventional PEG trochar. We use a Kellett needle
(Cook, UK; Figure 5) although other similar needles are
commercially available. This is a 15cm needle with a 19G
stylet, and a 5Fr outer sheath which was ﬁrst described for
use in percutaneous cholecystlithotomy [9]. Being longer
than a conventional PEG trochar it is often useful because its
longer“reach”mayfacilitategutpunctureinpatientswhoare
overweight or have omental malignancy; furthermore withDiagnostic and Therapeutic Endoscopy 3
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Figure 3: A Kellett drainage access needle is then inserted along a
similar entry path to the 21G needle, prior to snaring (panels (a)
and (b)).
its narrow gauge (in comparison with some PEG trochars),
it is relatively easy to puncture a mobile loop of small bowel
with this needle. Thus if the jejunum is tethered to or very
close to the abdominal wall, then we use a conventional
PEG trochar, but if diﬃculty in puncturing the gut lumen is
anticipated then a drainage access needle is used. As with the
“searching” 21G needle, intermittent ﬂuoroscopy is helpful
with this needle to guide its directional placement and to
help ensure that no interposed loops of bowel are punctured.
One important technical point is that only a single thread of
cotton (or nylon) will pass through the 5Fr sheath, which
means that the loop used in most “PEG” kits to advance
through the trochar sheath has to be cut at its apex, and
a single thread only is passed into the jejunum prior to
snaring. However, in our experience this has never prevented
successfulcompletionoftheDPEJprocedure.OncetheDPEJ
has been placed, we do not routinely do any further imaging
procedure and we generally start feeding within 24 hours.
3. Results
Forty patients (23 males, 17 females; median age 69) had
attempted DPEJ insertion between January 2002 and April
2008. Two patients prior to this series had unsuccessful
attempts without any further procedure and were not,
therefore, included in this review. A further two patients
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Figure 4: A cotton thread is passed into the Kellett needle and
through the snare, following which the procedure is completed
using the same technique as a conventional PEG.
Figure 5: Kellett drainage access needle.
within this case series had an unsuccessful procedure at the
ﬁrst attempt (due to restlessness), but then had a successful
DPEJ with general anaesthesia at the second attempt. Of the
remaining 38 cases in this series, all but one (see below) were
successful at the ﬁrst attempt.
Of the 40 patients in this series, 27 (67%) had previous
or current upper GI malignancy (oesophagus 7; stomach 17;
pancreas 3). Of the 27 patients with a history of malignancy,
12 (44%) had incurable disease at presentation and did not
have surgery, and 15 (56%) had undergone surgery with4 Diagnostic and Therapeutic Endoscopy
Table 1: Indications for DPEJ insertion in our cohort of patients.
Case description Number
Oesophageal malignancy, incurable 1
Gastric malignancy, incurable 10
Pancreatic malignancy, incurable 3
Oesophageal malignancy, postoperative
recurrence
5
Gastric malignancy, postoperative recurrence 4
Upper GI malignancy, postoperative malnutrition 4
Postoperative malnutrition (benign disease) 3
Acute cerebrovascular disease (stomach resected) 3
Gastric dysmotility 3
Cerebral palsy 2
Pancreatitis 2
resection of malignancy. Of the 15 postoperative cases, 11/15
(73%) had recurrent malignancy prior to DPEJ insertion;
in these cases the median interval from surgery to DPEJ
insertion was 12 months. Thus 23 out of 27 cases (85%)
with malignancy had inoperable or recurrent disease. The
remaining 4 cases without recurrent malignancy had DPEJ
insertion because of inability to maintain oral nutrition
d e s p i t ec u r a t i v es u r g e r y .
The 13 cases without GI malignancy comprised 3 cases
of gastroparesis (one diabetic, two idiopathic); 3 cases of
acute cerebrovascular disease (all had previous gastrectomy
for peptic ulcer disease); 3 postoperative cases with surgical
complicationsofbenigndisease(2perforatedduodenalulcer
with postoperative ﬁstula or gastroparesis and 1 duodenal
stenosis after aneurysm repair); 2 cases of cerebral palsy
with hiatus hernia and reﬂux disease; 2 cases of complicated
pancreatitis.IndicationsforDPEJaresummarisedinTable 1.
DPEJ insertion was done with a drainage access needle
in 16/40 cases (40%). Fluoroscopy was used in 19/40 cases
(47%), with a median ﬂuoroscopy time of 1.2 minutes.
Generalanaesthesiawasusedin5/40cases(12%).Remaining
cases were done using a conventional 10cm PEG trochar,
without ﬂuoroscopy and with conscious sedation. The
median endoscopic procedure time was 20 minutes (range
15–33). One case of failed DPEJ insertion was in a patient
with late postoperative dysmotility after oesophagogastrec-
tomy;inthispatientthejejunumcouldnotbeaccessedsafely,
despite ﬂuoroscopy because of interposed distended colon,
and no further was attempted thereafter.
There were no consistent clinical diﬀerences between
cases that did or did not require the drainage access needle
for success. In 21 patients who had had previous upper GI
resection or anastomosis for any reason, 8/21 (35%) had
their DPEJ done with this needle, which was similar to 8/18
(44%) done with the drainage access needle in the remaining
18 patients who had had no resection. However, certain
clinical situations made the procedure more likely to succeed
with the drainage access needle; three examples are given in
Table 2.
There were no technical complications encountered, that
is, no cases of perforation, peritonitis, or gastrointestinal
haemorrhage, and no patients required early DPEJ removal
for peristomal sepsis or other complication. However, overall
30 day mortality was relatively high at 14/40 (35%), reﬂected
advanced malignancy in most cases. The median survival
in patients with incurable malignancy, including those with
postoperative recurrent disease (23 patients in total), was 30
days (range 9 to 83). In patients with benign indications for
DPEJ insertion (16 patients in total), the 30-day mortality
was 3/16 (19%); each of these early deaths occurred in
patientswithacutecerebrovasculardiseaseandpriorgastrec-
tomy (two had aspiration pneumonia and one had a new
cerebrovascular event). Of the remaining 13 patients with
benign indications for DPEJ, 12 are still alive at the time of
this review (median follow-up 36 months).
Most patients (30/39, 77%) were discharged from hospi-
tal after DPEJ insertion and most (27/30, 90%) continued to
use the DPEJ for nutritional support following discharge and
until death; in the remaining 2 cases it was no longer needed
following discharge.
DPEJs were removed in 8 cases; all of these patients had
benign disease or curative surgery. In 3 cases the DPEJ was
removed at the time of further surgery for benign disease
in 3 cases the DPEJ was no longer required; in 2 cases there
wasseepageofbiliouscontentsfromtheDPEJsiteinpatients
where requirement for continued support was equivocal (in
these cases the DPEJ was removed at 5 and 6 months resp.).
The DPEJs were removed by traction following endoscopic
snaring,exceptinonecase,wherea“cutandpush”technique
was used, without further complication.
4. Discussion
DPEJ remains a technique in evolution, with varying
techniques described by diﬀerent authors in recent years.
Variations include the types of endoscope and PEG kits
used, usage (or otherwise) of ﬂuoroscopy and/ or transil-
lumination, and type of needle used for entry into the gut
lumen. In our case series we aimed to make best use of
all available alternatives in order to maximise success rate,
and this resulted in a high overall success rate compared
with previously published series, where technical success
rates ranged from 68% to 95% [5, 9–12]. The procedural
variations which we believe to be most important in
achieving a high success rate in this series were ﬁrstly the
selectiveusageofthedrainageaccessneedleforgutpuncture,
secondly the routine availability of ﬂuoroscopy, and thirdly
the selective usage of general anaesthesia.
Most previously described techniques for DPEJ insertion
do not specify length or needle gauge of trochar used,
although 16G and 18G needles have been described [11, 13].
We are unaware of any other reports of usage of the Kellett or
similar length needles. Conventional enteric access trochars
for gastrostomy or jejunostomy tend to be shorter (8cm or
less) and higher gauge (14G–18G) which may be diﬃcult
to puncture a mobile or deep loop of gut with. Techniques
that may help gut puncture with conventional trochars
includeusingtheendoscopetomobilisethejejunumtowards
the abdominal wall (made easier with a double balloonDiagnostic and Therapeutic Endoscopy 5
Table 2: Case summaries of three examples of DPEJ insertion where particular procedural diﬃculties were encountered, and where the
drainage access needle was helpful in ensuring a successful outcome. No case developed any complication.
Case Procedural challenge Technique
Male, 25. Severe cerebral palsy with
dysphagia and recurrent aspiration
pneumonia
Large paraoesophageal hernia with
proximal jejunum in thorax
Enteroscope with overtube used. Jejunum
punctured within thorax (via diaphragm-
atic hiatus from abdominal wall approa-
ch) with ﬂuoroscopic guidance
Female, 53. Pancreatic cancer with
partial duodenal obstruction and
peritoneal metastases
Large volume of omental malignancy
and moderate amount of ascites
Enteroscope used. Deep loop of jejunum
punctured with ﬂuoroscopic guidance
Female, 65. Gastric linitis plastica with
peritoneal metastases
Overweight patient with mobile
jejunum
Enteroscope used. Jejunum punctured
with ﬂuoroscopic guidance
enteroscope) and snaring the pilot 21G needle to help “ﬁx”
the gut wall against the abdominal wall and on occasions
we have used these techniques [9, 14]. However, situations
suchasomentalmalignancy,hiatushernia,orobesityremain
a challenge and having adopted the drainage access needle
early in our practice we have found this to be invaluable in
such situations.
We found ﬂuoroscopy to be particularly helpful where
the drainage access needle was used and believe that this
improves the safety of the procedure. Other published series
of percutaneous jejunostomy insertion with ﬂuoroscopy
do not report bowel perforation, in contrast to some
serieswithoutﬂuoroscopy,whereoccasionalperforationsare
described [13, 15, 16].
Some clinicians recommend transillumination to guide
abdominal wall puncture and give failure to transilluminate
as a reason for procedural failure [5, 9, 12, 17]. In our
practice we do not routinely use transillumination, although
we recommend ﬂuoroscopy in cases where neither transillu-
mination nor close ﬁnger indentation can be seen.
As with other DPEJ series, the presence of surgical scars
following previous bowel resection did not pose a signiﬁcant
hazard in our experience; indeed since the small bowel is
likely to be tethered to the abdominal wall in such cases,
DPEJ insertion may actually be easier [11, 18].
Regarding postprocedure complications, the possibility
of aspiration pneumonia is a particular concern. Avoidance
of this complication requires careful case selection and a
technique that minimises procedure time. The only two
patients in our series who died of aspiration pneumonia
both had benign disease and prior gastrectomy. Others
have noted a higher incidence of aspiration pneumonia in
patients undergoing DPEJ after gastrectomy [18]. Delayed
complications in the form of peristomal leakage occurred in
two patients in our series. This has been noted by others and
is a potential concern in patients with benign disease, where
long-term feeding is required [9]. However, should DPEJ
removal be required, then our usage of 15Fr PEG catheters
has not so far led to any cases of persisting enterocutaneous
ﬁstulaorothercomplications,unlikesomeotherserieswhere
larger diameter catheters had been used [17, 19].
Our 30-day mortality was high at 35% but this reﬂected
advanced malignancy in most cases, and there were no cases
of death resulting from technical complications. There is
little data on 30-day mortality in other similar case series
in the literature. In two case series of similar size, but each
with fewer cases of advanced malignancy, mortality rates of
17% and 29%, respectively, were reported [11, 16]. In two
larger case series, 30-day mortality rates are not reported
[5, 12]. The cost eﬀectiveness of artiﬁcial nutrition via DPEJ
feedinginpatientswithadvancedmalignancyandlimitedlife
expectancyremainsuncertainanddeservingoffurtherstudy,
but we believe that the technique can be an important aid to
palliation in appropriately selected cases.
In summary, where postpyloric feeding is required for
artiﬁcial nutritional support, the DPEJ technique that we
have described combines a high procedural success rate with
a low complication rate. Selective usage of a long drainage
access needle can help maximise the success rates and thus
clinical applications of DPEJ insertion.
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